1
Evaluating the Efficacy and Safety of Oral Ranirestat (40 and 80 mg) in Mild to Moderate Diabetic Sensorimotor Polyneuropathy
Condition(s):Mild to Moderate Diabetic Sensorimotor PolyneuropathyLast Updated:February 21, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Mild to Moderate Diabetic Sensorimotor PolyneuropathyLast Updated:February 21, 2019Completed
Condition(s):Diabetic NeuropathyLast Updated:January 14, 2008Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.